BRIEF-GSK CEO expects successor to be named towards end of 2016
April 27, 2016 at 07:48 AM EDT
April 27 (Reuters) - GlaxoSmithKline Chief Executive Andrew Witty told reporters:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.